Navigating the Complexities of Litigation Funding Discovery
February 12, 2024, 10:00 AM
For those who have not had a chance to attend one of our CLE presentations on Litigation Funding Disclosure, this IAM article provides a glimpse of the complex landscape for defendants seeking discovery on litigation funding topics in their cases. Litigation funding can significantly impact the parties’ ability to reach settlement. In some instances, uncovering details of litigation funding may even provide recourse for defendants under 35 U.S.C. § 285 against otherwise judgment-proof plaintiffs.
Defendants not in front of Judge Connolly in the District of Delaware often face an uphill battle in obtaining discovery regarding litigation funding (i.e., the identity of the funder and the funding terms/conditions). Our analysis indicates that certain approaches fare better than others. For example, seeking litigation-funding related discovery to rebut a plaintiff’s “David vs. Goliath” story may be more successful than seeking such discovery on the basis of potential standing issues. At least 24 out of the 94 Federal District Courts have local rules or some form of mechanism for disclosure of the identity of litigation funders in civil cases. Even in the Western District of Texas, this takes the form of an approved interrogatory. A well-informed strategy can maximize the chances for a defendant to obtain and leverage litigation funding discovery.
There is plenty of debate within the US patent community about whether patent holders who use third-party litigation funding should have to tell courts and accused infringers about it. What makes the conversation even more fraught is the rules that differ from jurisdiction to jurisdiction.

To subscribe to our publications, click here.
News & Insights
News & Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust